The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study-Reference-Cited by-同舟云学术

The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study

Published:2014-06-02 Issue:1 Volume:3 Page:
ISSN:2047-9158
Container-title:Translational Neurodegeneration
language:en
Short-container-title:Transl Neurodegener

Author:

Wang Ying,Sun Shenggang,Zhu Suiqiang,Liu Chunfeng,Liu Yiming,Di Qing,Shang Huifang,Ren Yan,Lu Changhong,Gordon Mark Forrest,Juhel Nolwenn,Chen Shengdi,

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Cognitive Neuroscience,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1186/2047-9158-3-11.pdf

Reference17 articles.

1. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B: The economic cost of brain disorders in Europe. Eur J Neurol. 2012, 19 (1): 155-162.

2. Tian YY, Tang CJ, Wu J, Zhou JS: Parkinson’s disease in China. Neurol Sci. 2011, 32 (1): 23-30.

3. Müller T: Drug therapy in patients with Parkinson’s disease. Transl Neurodegeneration. 2012, 1: 10-

4. Rascol O, Goetz C, Koller W, Poewe W, Sampaio C: Treatment interventions for Parkinson’s disease: an evidence based assessment. Lancet. 2002, 359 (9317): 1589-1598.

5. Pinter MM, Pogarell O, Oertel WH: Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson’s disease: a double blind, placebo controlled, randomised, multicentre study. J Neurol Neurosurg Psychiatry. 1999, 66 (4): 436-441.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson’s Disease;Brain Sciences;2024-07-31

2. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial;Drug Design, Development and Therapy;2023-08

3. Efficacy of pramipexole on quality of life in patients with Parkinson’s disease: a systematic review and meta-analysis;BMC Neurology;2022-08-25

4. Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease;npj Parkinson's Disease;2022-06-01

5. Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery;Biochemical Pharmacology;2022-01